Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Acquired resistance to crizotinib from a mutation in CD74-ROS1.

Acquired resistance to crizotinib from a mutation in CD74-ROS1. N Engl J Med. 2013 09 19; 369(12):1173.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.